检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:薛建芳[1] 余月琴[1] 伊艳如 毕华[1] XUE Jian-fang;YU Yue-qin;YI Yan-ru;BI Hua(Department of Obstetrics and Gynecology,Huzhou Hospital of Traditional Chinese Medicine,Huzhou,Zhejiang 313000,China)
出 处:《中国妇幼保健》2024年第7期1307-1310,共4页Maternal and Child Health Care of China
基 金:浙江省湖州市科技计划项目(2019GYB34)。
摘 要:目的探讨卵巢癌患者的人附睾蛋白4(HE4)、miR-200a、抗心磷脂抗体(ACA)表达变化及诊断价值。方法选取2020年3月—2022年6月湖州市中医院收治的25例卵巢癌患者和25例健康志愿者为研究对象,依次纳入病例组、健康组;收集病例组患者的临床分期资料,检测两组研究对象的HE4、miR-200a及ACA表达差异,绘制ROC曲线分析HE4、miR-200a及ACA指标对诊断卵巢癌的临床效能。结果与健康组比较,病例组的HE4、miR-200a及ACA均呈高表达(P<0.05);HE4、miR-200a及ACA 3项检查联合诊断准确率、AUC、灵敏度及特异度均明显高于单独诊断(t=27.458、30.158、11.645、21.867、19.421,均P<0.05)。结论HE4、miR-200a和ACA在卵巢癌患者中异常高表达,HE4、miR-200a及ACA 3项可作为卵巢癌重要的肿瘤标记物,3项联合诊断可以作为卵巢癌筛查的有效参考方案。Objective To investigate the expression and diagnostic value of Humanepididymisprotein4(HE4),miR-200a and Anticardiolipin(ACA)in patients with ovarian cancer.Methods A total of 25 patients with ovarian cancer and 25 healthy volunteers admitted to our hospital from March 2020 to June 2022 were selected as the research objects,and were successively included in the case group and the healthy group.The clinical stage data of the case group were collected,and the expression differences of HE4,miR-200a and ACA between the two groups were detected.The ROC curve was drawn to analyze the clinical efficacy of HE4,miR-200a and ACA indicators in the diagnosis of ovarian cancer.Results Compared with the healthy group,the case group had high expressions of HE4,miR-200a and ACA(t=27.458,30.158,11.645,21.867,19.421,all P<0.05).The accuracy,AUC,sensitivity and specificity of combined diagnosis of HE4,miR-200a and ACA significantly increased than those of single diagnosis(P<0.05).Conclusion HE4,miR-200a and ACA are abnormally highly expressed in patients with ovarian cancer.HE4,miR-200a and ACA can be used as important tumor markers for ovarian cancer,and their combined diagnosis can be used as an effective reference program for ovarian cancer screening.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249